Back to search results
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the
risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal or
oropharyngeal viral shedding.
Status: Open/Actively Recruiting
Rafael Corona Jr.